Showing 581-590 of 7123 results for "".
Engagement: Still Key to Healthcare Marketing in the Digital Age
https://practicaldermatology.com/topics/general-topics/engagement-still-key-to-healthcare-marketing-in-the-digital-age/21671/New economic conditions call for a strategy shift in medical practice management, and new digital opportunities can play an important roleEvaluating Hyaluronic Acids in Patients with Skin of Color
https://practicaldermatology.com/topics/general-topics/1109_05-php/22057/One expert places new findings in perspective and explains why new data on fillers in skin of color are essential.Atypical Sweet Syndrome: A Case Report and Brief Literature Review
https://practicaldermatology.com/topics/rare-disease/atypical-sweet-syndrome-a-case-report-and-brief-literature-review/23610/A case highlights the complexity of this diagnosis, including its management and workup, especially when pathology findings are atypical.Maui Derm 2024 and Maui Derm Caribbean: Top Stories, Interviews, and More
https://practicaldermatology.com/conferences/maui-derm-2024/maui-derm-2024-and-maui-derm-caribbean-top-stories-interviews-and-more/24043/The sun was bright, and the science was hot at Maui Derm 2024, held at the Grand Wailea Resort in Maui, Hawaii. From new therapies to innovative techniques to treatments in the pipeline, presenters and attendees were eager to share updates and findings at this popular annual event.New Drugs in Psoriasis
https://practicaldermatology.com/topics/psoriasis/new-drugs-in-psoriasis/20933/The last two years have seen a number of new drugs approved to treat psoriasis—from targeted biologics to new topicals.Seborrheic Dermatitis Update: A Review of the Etiology and Treatment of Seborrheic Dermatitis
https://practicaldermatology.com/programs/practical-dermatology/seborrheic-dermatitis-update-a-review-of-the-etiology-and-treatment-of-seborrheic-dermatitis/24003/Seborrheic dermatitis (SD) is an inflammatory skin condition that often involves flaky, erythematous patches on sebum-rich areas of the body such as the face and scalp.1 At least 50 million Americans have a form of seborrheic dermatitis on the scalp, more commonly known as dandruff. SD presents in aPrurigo Nodularis: An Update for Clinicians, Part 1
https://practicaldermatology.com/topics/general-topics/prurigo-nodularis-an-update-for-clinicians-part-1/20507/Here's a look at the diagnosis of an “eczematous” condition with an unclear etiology.Mineral Sunscreens with Iron Oxides are Underused for Dyschromia in Skin of Color
https://practicaldermatology.com/topics/skin-of-color/mineral-sunscreens-with-iron-oxides-are-underused-for-dyschromia-in-skin-of-color/23697/A local survey highlights the opportunity for dermatologists to counsel and educate skin of color patients on the use of tinted mineral sunscreens for bothersome dyschromia.The Excoriated and Bleeding Edge: Updates in Eczema for the Clinician
https://practicaldermatology.com/topics/general-topics/the-excoriated-and-bleeding-edge-updates-in-eczema-for-the-clinician/21469/Atopic dermatitis continues to present treatment challenges, but a steady juggling of four main components—moisturization, antibiotics, anti-inflammatory, and antipruritics— help to maximize control of the disease.Is Topical Therapy for Psoriasis Resurging?
https://practicaldermatology.com/topics/psoriasis/PD0409_03-php/22841/While biologics have changed the way patients and physicians think about psoriasis, topical therapy remains important for a majority of patients.